1. Home
  2. AN vs SYRE Comparison

AN vs SYRE Comparison

Compare AN & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$184.23

Market Cap

6.4B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$73.21

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AN
SYRE
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.3B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
AN
SYRE
Price
$184.23
$73.21
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$244.33
$85.08
AVG Volume (30 Days)
352.7K
941.4K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
0.71
N/A
EPS
5.85
N/A
Revenue
$27,631,400,000.00
N/A
Revenue This Year
$4.32
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$31.38
N/A
Revenue Growth
3.24
N/A
52 Week Low
$176.62
$13.93
52 Week High
$228.92
$78.80

Technical Indicators

Market Signals
Indicator
AN
SYRE
Relative Strength Index (RSI) 39.55 56.62
Support Level N/A $67.18
Resistance Level $214.85 $76.16
Average True Range (ATR) 6.12 4.18
MACD -2.24 -1.19
Stochastic Oscillator 29.71 57.96

Price Performance

Historical Comparison
AN
SYRE

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: